Resolve Medicolegal Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: SC432222 (Scotland)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2019

FOR

RESOLVE MEDICOLEGAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr M Broadbent

Mr P M S Simpson

Mr D Q Donaldson

Mr R A E Clayton

REGISTERED OFFICE:

c/o Mr M Broadbent

No 2, The Arc

25 Colquhoun Avenue

Hillington Park

Glasgow

G52 4BN

REGISTERED NUMBER:

SC432222 (Scotland)

FIXED ASSETS

Tangible assets

4

10,934

16,662

CURRENT ASSETS

Debtors

5

92,902

100,648

Cash at bank

159,803

57,734

252,705

158,382

CREDITORS

Amounts falling due within one year

6

101,311

58,295

NET CURRENT ASSETS

151,394

100,087

TOTAL ASSETS LESS CURRENT LIABILITIES

162,328

116,749

PROVISIONS FOR LIABILITIES

2,077

-

NET ASSETS

160,251

116,749

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

160,151

116,649

SHAREHOLDERS' FUNDS

160,251

116,749

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 4 February 2020 and were signed on its behalf by:

Mr M Broadbent - Director

1.	STATUTORY INFORMATION

Resolve Medicolegal Limited is a private company, limited by shares , registered in Scotland.

The company's registered number and registered office address can be found on the

Company Information page.

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER

The turnover shown in the profit and loss account represents amount earned during the

year and is recognised when the company obtains the right to consideration.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Improvements to property

-

20% on cost

Fixtures and fittings

-

15% on reducing balance

All fixed assets are initially recorded at cost.

TAXATION

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income

Statement, except to the extent that it relates to items recognised in other comprehensive

income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that

have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not

reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in

periods different from those in which they are recognised in financial statements. Deferred

tax is measured using tax rates and laws that have been enacted or substantively enacted

by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it

is probable that they will be recovered against the reversal of deferred tax liabilities or

other future taxable profits.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to

the company's pension scheme are charged to profit or loss in the period to which they

relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2018 - 14 ) .

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

and

property

fittings

Totals

£

£

£

COST

At 1 October 2018

20,346

21,294

41,640

Additions

-

271

271

At 30 September 2019

20,346

21,565

41,911

DEPRECIATION

At 1 October 2018

16,277

8,701

24,978

Charge for year

4,069

1,930

5,999

At 30 September 2019

20,346

10,631

30,977

NET BOOK VALUE

At 30 September 2019

-

10,934

10,934

At 30 September 2018

4,069

12,593

16,662

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

£

Trade debtors

82,461

85,498

Other debtors

2,233

2,477

Prepayments and accrued income

8,208

12,673

92,902

100,648

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

£

Tax

15,806

11,031

VAT

47,842

24,553

Accrued expenses

37,663

22,711

101,311

58,295

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2019

2018

value:

£

£

100

Ordinary

£1

100

100

8.	RELATED PARTY DISCLOSURES

Throughout the year the company paid £18,000 (2018 - £18,000) to Broadbent Legal

Services Limited, a company in which Mr Broadbent is a Director and Shareholder, for

Management Consultancy. The balance owing as at the balance sheet date was £Nil (2018 -

£Nil).

Throughout the year the company paid £6,000 (2018 - £7,000) to Simpsons Orthopaedics

Limited, a company in which Mr Simpson is a Director and Shareholder, for Management

Consultancy. The balance owing as at the balance sheet date was £Nil (2018 - £Nil)

Throughout the year the company paid £6,000 (2018 - £7,000) to Mr D Donaldson for

Management Consultancy. The balance owing as at the balance sheet date was £Nil (2018 -

£Nil)

Throughout the year the company paid £6,000 (2018 - £6,500) to Clayton Medical, a

company in which Mr Clayton is a Director and Shareholder, for Management Consultancy.

The balance owing as at the balance sheet date was £Nil (2018 - £Nil).